Evaluation of Histone Demethylase Inhibitor ML324 and Acyclovir against Cyprinid herpesvirus 3 Infection
Viruses · 2023
DOI: 10.3390/v15010163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Shelby Matsuoka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA. Hauptthemen laut MEDLINE: Herpesviridae Infections, Carps, Herpesviridae, Fish Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Associated Koi Clubs of America and CCVM DVM summer research grant at Oregon State University.
Abstract (Originalsprache)
Cyprinid herpesvirus 3 (CyHV-3) can cause severe disease in koi and common carp (Cyprinus carpio). Currently, no effective treatment is available against CyHV-3 infection in koi. Both LSD1 and JMJD2 are histone demethylases (HD) and are critical for immediate-early (IE) gene activation essential for lytic herpesvirus replication. OG-L002 and ML324 are newly discovered specific inhibitors of LSD1 and JMJD2, respectively. Here, HD inhibitors were compared with acyclovir (ACV) against CyHV-3 infection in vitro and in vivo. ML324, at 20–50 µM, can completely block ~1 × 103 PFU CyHV-3 replication in vitro, while OG-L002 at 20 µM and 50 µM can produce 96% and 98% inhibition, respectively. Only about 94% inhibition of ~1 × 103 PFU CyHV-3 replication was observed in cells treated with ACV at 50 µM. As expected, CyHV-3 IE gene transcription of ORF139 and ORF155 was blocked within 72 h post-infection (hpi) in the presence of 20 µM ML324. No detectable cytotoxicity was observed in KF-1 or CCB cells treated for 24 h with 1 to 50 µM ML324. A significant reduction of CyHV-3 replication was observed in ~6-month-old infected koi treated with 20 µM ML324 in an immersion bath for 3–4 h at 1-, 3-, and 5-days post-infection compared to the control and ACV treatments. Under heat stress, 50–70% of 3–4-month-old koi survived CyHV-3 infection when they were treated daily with 20 µM ML324 in an immersion bath for 3–4 h within the first 5 d post-infection (dpi), compared to 11–19% and 22–27% of koi in the control and ACV treatments, respectively. Our study demonstrates that ML324 has the potential to be used against CyHV-3 infection in koi.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.
- Department of Microbiology, College of Science, Oregon State University, Corvallis, OR 97331, USA.
- Department of Fisheries, Wildlife, and Conservation Sciences, Oregon State University, Newport, OR 97365, USA.
ORCID-Profile: Christiane Lohr, Ling Jin
Förderung
- the Associated Koi Clubs of America and CCVM DVM summer research grant at Oregon State University
Zitieren
APA
Matsuoka, S., Petri, G., Larson, K., Behnke, A., Wang, X., Peng, M., Spagnoli, S., Lohr, C., Milston-Clements, R., Divilov, K., & Jin, L. (2023). Evaluation of Histone Demethylase Inhibitor ML324 and Acyclovir against Cyprinid herpesvirus 3 Infection. Viruses. https://doi.org/10.3390/v15010163
Vancouver
Matsuoka S, Petri G, Larson K, Behnke A, Wang X, Peng M, et al. Evaluation of Histone Demethylase Inhibitor ML324 and Acyclovir against Cyprinid herpesvirus 3 Infection. Viruses. 2023. doi:10.3390/v15010163
BibTeX
@article{Matsuoka2023,
author = {Matsuoka, Shelby and Petri, Gloria and Larson, Kristen and Behnke, Alexandra and Wang, Xisheng and Peng, Muhui and Spagnoli, Sean and Lohr, Christiane and Milston-Clements, Ruth and Divilov, Konstantin and Jin, Ling},
title = {Evaluation of Histone Demethylase Inhibitor ML324 and Acyclovir against Cyprinid herpesvirus 3 Infection},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15010163}
}
EUVIMED